BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9553811)

  • 41. [Lymphohistiocytic infiltration of endometrial adenocarcinoma].
    Böhme M; Löttge M; Schmidt D; Röse I; Weise W; Morenz J
    Zentralbl Gynakol; 1995; 117(5):247-52. PubMed ID: 7793166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Significance of Endometrial Cells in Papanicolaou Smears of Women Attending an Organized Cervical Cancer Screening Program.
    Repše-Fokter A
    Acta Cytol; 2015; 59(4):358-9. PubMed ID: 26339795
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
    Shawana S; Kehar SI; Masood S; Aamir I
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of histiocytes on otherwise-normal cervical smears from postmenopausal women. A retrospective study of 108 cases.
    Wen P; Abramovich CM; Wang N; Knop N; Mansbacher S; Abdul-Karim FW
    Acta Cytol; 2003; 47(2):135-40. PubMed ID: 12685178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear features in endometrial cytology: comparison of endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.
    Norimatsu Y; Shigematsu Y; Sakamoto S; Ohsaki H; Yanoh K; Kawanishi N; Kobayashi TK
    Diagn Cytopathol; 2012 Dec; 40(12):1077-82. PubMed ID: 22241733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endometrial brush cytology of advanced postmenopausal endometrium: does endometrial intraepithelial neoplasia exist in the absence of hyperplasia?
    Maksem JA
    Diagn Cytopathol; 1998 Nov; 19(5):338-43. PubMed ID: 9812226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of benign endometrial cells in postmenopausal women.
    Ashfaq R; Sharma S; Dulley T; Saboorian MH; Siddiqui MT; Warner C
    Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of HOXA10 in endometrial hyperplasia and adenocarcinoma and regulation by sex hormones in vitro.
    Zhong G; Wang Y; Liu X
    Int J Gynecol Cancer; 2011 Jul; 21(5):800-5. PubMed ID: 21670700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
    Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women.
    Buccoliero AM; Gheri CF; Castiglione F; Garbini F; Barbetti A; Fambrini M; Bargelli G; Pappalardo S; Taddei A; Boddi V; Scarselli GF; Marchionni M; Taddei GL
    Cytopathology; 2007 Aug; 18(4):241-9. PubMed ID: 17559564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.
    Jovanovic AS; Boynton KA; Mutter GL
    Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential of the learning vector quantizer in the cell classification of endometrial lesions in postmenopausal women.
    Karakitsos P; Kyroudes A; Pouliakis A; Stergiou EB; Voulgaris Z; Kittas C
    Anal Quant Cytol Histol; 2002 Feb; 24(1):30-8. PubMed ID: 11865947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
    McKenney JK; Longacre TA
    Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of thin-layer preparations in the endometrial cytology: evaluation of benign endometrial lesions.
    Norimatsu Y; Kouda H; Kobayashi TK; Moriya T; Yanoh K; Tsukayama C; Miyake Y; Ohno E
    Ann Diagn Pathol; 2008 Apr; 12(2):103-11. PubMed ID: 18325470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tenascin expression in normal, hyperplastic, and neoplastic endometrium.
    Sedele M; Karaveli S; Peştereli HE; Simşek T; Elpek G; Uner M; Sargin CF
    Int J Gynecol Pathol; 2002 Apr; 21(2):161-6. PubMed ID: 11917226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of the Endo-pap sampler in detecting endometrial lesions.
    van Hoeven KH; Zaman SS; Deger RB; Artymyshyn RL
    Acta Cytol; 1996; 40(5):900-6. PubMed ID: 8842164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
    Park CK; Yoon G; Cho YA; Kim HS
    Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE; Stenbäck F; Tapanainen JS
    Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Thin-layer cytology in endometrial diagnosis].
    Buccoliero AM; Caldarella A; Noci I; Borri P; Giachi M; Borrani E; Taddei GL
    Pathologica; 2003 Aug; 95(4):179-84. PubMed ID: 14577201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.